Dapagliflozin and metformin Sustained Release Tablets
Nov 02, 2022
Glidapaflozin
Dapagliflozin and metformin Sustained Release Tablets combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) disease or multiple cardiovascular risk factors.
For more information please contact:
Recent Post
Sitagliptin Phosphate (50mg) & Metformin HCl (500mg) – Uses, Benefits, and Dosage
Magaldrate & Simethicone Oral Suspension in STERIS ANTACID MSO.
Calcium Polystyrene Sulphonate Powder: Mechanism of Action and Side Effects.
Lymecycline Capsules bp 408 mg Tablet From Steris healthcare.
Managing Type 2 Diabetes with Gliclazide (40mg) and Metformin (500mg)
Tolvaptan 15mg: Uses, Dosage, Side Effects, and Benefits
Understanding Repaglinide 0.5mg: A Guide to Managing Type 2 Diabetes
Fluvoxamine (50mg): Understanding Its Mechanism of Action and Impact on Mental Health
Managing Gastroesophageal Reflux Disease with Domperidone 30mg and Pantoprazole 40mg
Carbimazole 5mg: Side Effects, Dosage Instructions, and Potential Interactions